Targeting NF-κB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4755-4763

  Wang, Honglin ^a,b   Syrovets, Tatiana ^b   Kess, Daniel ^b   Büchele, Berthold ^b   Hainzl, Heidi ^b   Lunov, Oleg ^b   Weiss, Johannes M ^b   Scharffetter Kochanek, Karin ^b   Simmet, Thomas ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL 11 OXO BETA BOSWELLIC ACID; CD18 ANTIGEN; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 23; MONOCYTE CHEMOTACTIC PROTEIN 1; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETYL 11 KETOBOSWELLIC ACID; ACETYL-11-KETOBOSWELLIC ACID; AUTACOID; NONSTEROID ANTIINFLAMMATORY AGENT; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PSORIASIS VULGARIS; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; ANIMAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE MUTANT; PSORIASIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION MEDIATORS; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; PSORIASIS; TRITERPENES;

EID: 70449711383     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900521     Document Type: Article

References (60)

1. Schön, M. P., and W. H. Boehncke. 2005. Psoriasis. N. Engl. J. Med. 352: 1899-1912.
2. 1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat. Med. 13: 836-842.
3. Marble, D. J., K. B. Gordon, and B. J. Nickoloff. 2007. Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. J. Dermatol. Sci. 48: 87-101.
4. Wang, H., T. Peters, D. Kess, A. Sindrilaru, T. Oreshkova, N. Van Rooijen, A. Stratis, A. C. Renkl, C. Sunderkotter, M. Wlaschek, et al. 2006. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116: 2105-2114.
5. Stratis, A., M. Pasparakis, R. A. Rupec, D. Markur, K. Hartmann, K. Scharffetter-Kochanek, T. Peters, N. van Rooijen, T. Krieg, and I. Haase. 2006. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J. Clin. Invest. 116: 2094-2104.
6. Clark, R. A., and T. S. Kupper. 2006. Misbehaving macrophages in the pathogenesis of psoriasis. J. Clin. Invest. 116: 2084-2087.
7. Leonardi, C. L., J. L. Powers, R. T. Matheson, B. S. Goffe, R. Zitnik, A. Wang, A. B. Gottlieb, and E. P. S. Group. 2003. Etanercept as monotherapy in patients with psoriasis. N. Engl. J. Med. 349: 2014-2022.
8. Boyman, O., C. Conrad, G. Tonel, M. Gilliet, and F. O. Nestle. 2007. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 28: 51-57. (Pubitemid 46176734)
9. Lowes, M. A., A. M. Bowcock, and J. G. Krueger. 2007. Pathogenesis and therapy of psoriasis. Nature 445: 866-873.
10. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.): S81-S96.
11. Lizzul, P. F., A. Aphale, R. Malaviya, Y. Sun, S. Masud, V. Dombrovskiy, and A. B. Gottlieb. 2005. Differential expression of phosphorylated NF-κB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept. J. Invest. Dermatol. 124: 1275-1283.
12. Xaus, J., M. Comalada, A. F. Valledor, J. Lloberas, F. Lopez-Soriano, J. M. Argiles, C. Bogdan, and A. Celada. 2000. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-α. Blood 95: 3823-3831. (Pubitemid 30412856)
13. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344-362.
14. Neumann, M., and M. Naumann. 2007. Beyond IκBs: alternative regulation of NF-κB activity. FASEB J. 21: 2642-2654. (Pubitemid 47372732)
15. Gottlieb, A., N. J. Korman, K. B. Gordon, S. R. Feldman, M. Lebwohl, J. Y. Koo, A. S. Van Voorhees, C. A. Elmets, C. L. Leonardi, K. R. Beutner, et al. 2008. Guidelines of care for the management of psoriasis and psoriatic arthritis, 2: Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J. Am. Acad. Dermatol. 58: 851-864. (Pubitemid 351509657)
16. Menter, A., A. Gottlieb, S. R. Feldman, A. S. Van Voorhees, C. L. Leonardi, K. B. Gordon, M. Lebwohl, J. Y. Koo, C. A. Elmets, N. J. Korman, et al. 2008. Guidelines of care for the management of psoriasis and psoriatic arthritis, 1: Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J. Am. Acad. Dermatol. 58: 826-850. (Pubitemid 351509656)
17. Guttman-Yassky, E., and J. G. Krueger. 2007. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Br. J. Dermatol. 157: 1103-1115. (Pubitemid 350115667)
18. Syrovets, T., J. E. Gschwend, B. Büchele, Y. Laumonnier, W. Zugmaier, F. Genze, and T. Simmet. 2005. Inhibition of IκB kinase activity by acetylboswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J. Biol. Chem. 280: 6170-6180. (Pubitemid 40280102)
19. Syrovets, T., B. Büchele, C. Krauss, Y. Laumonnier, and T. Simmet. 2005. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-α induction in monocytes by direct interaction with IκB kinases. J. Immunol. 174: 498-506. (Pubitemid 40007440)
20. Ammon, H. P. 2006. Boswellic acids in chronic inflammatory diseases. Planta Med. 72: 1100-1116. (Pubitemid 44638909)
21. Boehncke, W. H., and M. P. Schon. 2007. Animal models of psoriasis. Clin. Dermatol. 25: 596-605.
22. Gudjonsson, J. E., A. Johnston, M. Dyson, H. Valdimarsson, and J. T. Elder. 2007. Mouse models of psoriasis. J. Invest. Dermatol. 127: 1292-1308.
23. Wilson, R. W., C. M. Ballantyne, C. W. Smith, C. Montgomery, A. Bradley, W. E. O'Brien, and A. L. Beaudet. 1993. Gene targeting yields a CD18-mutant mouse for study of inflammation. J. Immunol. 151: 1571-1578.
24. Büchele, B., W. Zugmaier, and T. Simmet. 2003. Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography: identification of lupeolic acid, a novel pentacyclic triterpene. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 791: 21-30.
25. Büchele, B., and T. Simmet. 2003. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 795: 355-362.
26. Van Rooijen, N. 1989. The liposome-mediated macrophage "suicide" technique. J. Immunol. Methods 124: 1-6.
27. + T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J. Immunol. 171: 5697-5706.
28. Pasparakis, M., G. Courtois, M. Hafner, M. Schmidt-Supprian, A. Nenci, A. Toksoy, M. Krampert, M. Goebeler, R. Gillitzer, A. Israel, et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866.
29. Li, Q., Y. Laumonnier, T. Syrovets, and T. Simmet. 2007. Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 27: 1383-1389.
30. Akiyama, M., Y. Sugiyama-Nakagiri, K. Sakai, J. R. McMillan, M. Goto, K. Arita, Y. Tsuji-Abe, N. Tabata, K. Matsuoka, R. Sasaki, et al. 2005. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J. Clin. Invest. 115: 1777-1784.
31. Udalova, I. A., J. C. Knight, V. Vidal, S. A. Nedospasov, and D. Kwiatkowski. 1998. Complex NF-κB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273: 21178-21186.
32. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide- mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171: 35-47.
33. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell Biol. 10: 1498-1506.
34. + macrophages. J. Clin. Invest. 117: 2517-2525.
35. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453-461.
36. -/- mice. Arterioscler. Thromb. Vasc. Biol. 28: 272-277.
37. Ghosh, S., and M. S. Hayden. 2008. New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8: 837-848.
38. Andreakos, E., B. Foxwell, and M. Feldmann. 2004. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202: 250-265. (Pubitemid 39576917)
39. Teferedegne, B., M. R. Green, Z. Guo, and J. M. Boss. 2006. Mechanism of action of a distal NF-κB-dependent enhancer. Mol. Cell. Biol. 26: 5759-5770. (Pubitemid 44134332)
40. Boyman, O., H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle. 2004. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199: 731-736. (Pubitemid 38316440)
41. Kaufman, C. K., and E. Fuchs. 2000. It's got you covered: NF-κB in the epidermis. J. Cell Biol. 149: 999-1004.
42. Kielar, D., W. E. Kaminski, G. Liebisch, A. Piehler, J. J. Wenzel, C. Mohle, S. Heimerl, T. Langmann, S. O. Friedrich, A. Bottcher, et al. 2003. Adenosine triphosphate binding cassette (ABC) transporters are expressed and regulated during terminal keratinocyte differentiation: a potential role for ABCA7 in epidermal lipid reorganization. J. Invest. Dermatol. 121: 465-474.
43. Gerondakis, S., R. Grumont, R. Gugasyan, L. Wong, I. Isomura, W. Ho, and A. Banerjee. 2006. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 25: 6781-6799. (Pubitemid 44657852)
44. Gottlieb, A. B., F. Chamian, S. Masud, I. Cardinale, M. V. Abello, M. A. Lowes, F. Chen, M. Magliocco, and J. G. Krueger. 2005. TNF inhibition rapidly downregulates multiple proinflammatory pathways in psoriasis plaques. J. Immunol. 175: 2721-2729.
45. Clark, I. A. 2007. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18: 335-343.
46. Ballard, D. W., E. Bohnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241: 1652-1655.
47. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15: 5258-5267.
48. Beverley, P. C. 2008. Primer: making sense of T-cell memory. Nat. Clin. Pract. Rheumatol. 4: 43-49.
49. Carmody, R. J., Q. Ruan, H. C. Liou, and Y. H. Chen. 2007. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J. Immunol. 178: 186-191.
50. Lee, E., W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, and J. G. Krueger. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199: 125-130. (Pubitemid 38076484)
51. Chan, J. R., W. Blumenschein, E. Murphy, C. Diveu, M. Wiekowski, S. Abbondanzo, L. Lucian, R. Geissler, S. Brodie, A. B. Kimball, et aL. 2006. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203: 2577-2587.
52. Nair, R. P., K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, et al. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41: 199-204.
53. Gareus, R., M. Huth, B. Breiden, A. Nenci, N. Rosch, I. Haase, W. Bloch, K. Sandhoff, and M. Pasparakis. 2007. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat. Cell Biol. 9: 461-469. (Pubitemid 46511080)
54. Hu, Y., V. Baud, T. Oga, K. I. Kim, K. Yoshida, and M. Karin. 2001. IKKα controls formation of the epidermis independently of NF-κB. Nature 410: 710-714. (Pubitemid 32290360)
55. Seitz, C. S., Q. Lin, H. Deng, and P. A. Khavari. 1998. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. USA 95: 2307-2312.
56. Sil, A. K., S. Maeda, Y. Sano, D. R. Roop, and M. Karin. 2004. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664.
57. Takeda, K., O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284: 313-316. (Pubitemid 129523448)
58. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
59. Kary, S., M. Worm, H. Audring, D. Huscher, M. Renelt, H. Sorensen, E. Stander, U. Maass, H. Lee, W. Sterry, and G. R. Burmester. 2006. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists. Ann. Rheum. Dis. 65: 405-407.
60. Collamer, A. N., K. T. Guerrero, J. S. Henning, and D. F. Battafarano. 2008. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 59: 996-1001.